Telos Corporation Announces Third Quarter 2026 Financial Results Date
Telos Corporation has scheduled the release of its third quarter 2026 financial results for November 9, 2026.
Stocks · News reference
Tiziana Life Sciences Announces Submission Of FDA Orphan Drug Designation Request For Foralumab In Multiple System Atrophy
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Shares of software companies are trading lower amid a broader technology sell-off led by declines in Micron and other semiconductor stocks. Comments from Intel and Broadcom CEOs that limited access to capital could constrain AI expansion, despite strong demand for computing infrastructure, are adding to concerns about the sustainability of tech-sector growth.
U.S. Cybersecurity Agencies Warn China-Based Cybersecurity Company Enabling Threat Actors To Target Multiple Critical Infrastructure Sectors Worldwide
Telos Awarded 3-Yr, $13.5M Contract By 16th Air Force To Provide Continued Support For US AF ISR Systems Operating Across Air Force Intelligence Community
Telos Corporation (NASDAQ:TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced it has been awarded a three-year, $13.5 million